IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Georgia

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Georgia $ 15,165,946.20
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Abeome Corporation Discovery of monocional antibodies for cancer therapeutic and biomarker development $ 244,479.24  
Access Product Marketing, LLC Project APM01050 - Patient friendly delivery of glucagon for emergency treatment of severe hypoglycemia $ 207,410.00 $ 37,069.25
AerovectRx Corporation AerovectRx disposable drug cartridge (DDC) compatibility and stability $ 32,200.00 $ 90,800.00
Alaven Pharmaceutical LLC CALM-UC Clinical Assessment of Low Dose Mesalamine in Uncerative Colitis $ 244,479.25  
Alimera Sciences Inc. Iluvien for the Treatment of Diabetic Macular Edema $ 244,479.25  
ALTEA THERAPEUTICS ENOXPARIN SODIUM PASSPORT ® SYSTEM $ 244,479.25  
ALTEA THERAPEUTICS CORP EXENATIDE PASSPORT(R)STEM $ 244,479.25  
Altiris Therapeutics, Inc.  ALT-118 $ 244,479.25  
Apeliotus Vision Science, Inc. Diagnostic for Age-Related Macular Degeneration $ 96,546.00 $ 147,933.25
Argent Diagnostics Inc High Sensitivity Nano-Optical Method to Detect Measles Virus $ 6,222.00 $ 28,904.50
Atlanta Catheter Therapies, Inc (ACT) Prototype development and Pre-Clinical testing of Occlusion Perfusion Catheter $ 160,112.00 $ 84,367.24
Axona Inc. (dba AxoTect, Inc.) Calpain inhibitors for Cancer Related Neuropathies $ 64,939.50 $ 87,500.00
Cardiac regeneration Technologies, LLC CardioGold Project $ 174,527.00 $ 69,952.25
CardioMEMS Inc CardioMEMS Heart Failure System (CardioMEMS HF-system) $ 244,479.25  
Carticept Medical, Inc Navigator™ Delivery System $ 244,479.24  
Cell Constructs Inc Autologous Stem Cell Therapy Dressing for Chronic Wounds $ 15,787.50 $ 108,808.00
CeloNova BioSciences, Inc. Safety and Efficacy of Embozene Microspheres for Uterine Artery Embolization for SUF   $ 244,479.25
CeloNova BioSciences, Inc. Safety and Efficacy of a Newly Designed Coronary Stent Coated with Polyzene-F   $ 244,479.25
CeloNova BioSciences, Inc. Target Drug Delivery Device: OncoZene Drug Eluting Microspheres $ 244,479.25  
Celtaxsys Inc Chemorepulsion Project $ 244,479.24  
CorMatrix Cardiovascular Inc ECM Emulsion Injection Therapy to Treat Myocardial Ischemia $ 244,479.24  
CorMatrix Cardiovascular Inc Reduction of Postoperative Atrial Fibrillation using Co-Matrix ECM $ 170,526.57 $ 73,952.67
CorMatrix Cardiovascular Inc Tissue Regenerating ECM for Vascular Applications $ 108,602.13 $ 135,877.11
CorMatrix Cardiovascular Inc New method to decellularize and sterlize Xenografts for optimized host integration   $ 220,709.83
CorMatrix Cardiovascular Inc Drug-eluting ECM for Pericardial Reconstruction   $ 213,668.94
Effcon Laboratories Inc Alcohol Abuse Treatment $ 2,730.00 $ 167,775.00
Effcon Laboratories, Inc. Glaucoma Project $ 76,540.00 $ 167,939.25
Effcon Laboratories, Inc. Lice Project $ 8,190.00 $ 236,289.25
Effcon Laboratories, Inc. Dystonia Project $ 22,800.50 $ 221,678.75
Envisionier Medical Technologies, Inc endogo®HD, endoscopic imaging system $ 159,992.00 $ 48,504.50
Femasys Inc. FemVue Systems $ 244,479.25  
Femasys Inc. FemBloc Permanent Contraceptive System $ 244,479.25  
GeneCure LLC Development of therapeutic HIV vaccines $ 244,479.24  
GeoVax, Inc HIV/AIDS Vaccine $ 244,479.24  
Glycosensors and Diagnostics, LLC High-specificity affinity reagents for N-glycosylation site mapping and glycomics $ 33,307.98 $ 84,709.16
Guided Therapeutics, Inc. Cost Effective Noninvasive Cervical Cancer Detection System $ 244,479.24  
Health Discovery Corporation Health Discovery Corporation's SVM and RFE-SVM Technology $ 109,323.02 $ 135,156.23
ICON Interventional Systems, Inc. ICON® NULOY® Drug Eluting Stent (DES) Platform $ 244,479.25  
Iconic Therapeutics, Inc. Iconic Therapeutics, Inc.: Development of I-con1 $ 244,479.25  
Inhibikase Therapeutics Inc Host-targeted antiviral for seasonal and pandemic influenza $ 76,207.50 $ 168,271.74
Inhibikase Therapeutics Inc Antiviral treatment for progressive multifocal leukoencephalopathy $ 61,799.50 $ 182,679.74
Inhibikase Therapeutics Inc Antiviral treatment for polyomavirus-associated nephropathy $ 61,799.50 $ 182,679.74
INHIBITEX, INC FV-100 $ 244,479.24  
INHIBITEX, INC INX-189 $ 244,479.24  
InVasc Therapeutics, Inc INV-140 Series $ 137,557.00 $ 106,922.25
LEXICOR MEDICAL TECHNOLOGY, LLC NEBA-M(NEUROPSYCHIATRIC EEG-BASED ASSESSMENT AID-Major Depressive Disorder)   $ 244,479.25
Lexicor Medical Techonology LLC NEBA (neuropsychiatric eeg-based ADHD assessment Aid $ 244,479.24  
Luminomics Inc Degenerative Disease models in zebrafish $ 184,394.18 $ 60,085.07
MD Innovate, Inc PneumoniaCheck-A Therapeutic Discovery Project   $ 244,479.25
Metabolic Testing Services, Inc. Metabolic Testing for Early Detection & Treatment of Heart Disease $ 244,479.24  
MiMedx Group, Inc. CollaFix Therapeutic Delivery $ 244,479.25  
NeurOp, Inc Neuroprotection by pH Sensitive Antagonists to the NMDA NR2B Receptor $ 198,809.00 $ 45,670.25
Revogenex, Inc. RVX-108 (CDP-CB) IND 105,579 Chlorideazepoxide Hydrochloride $ 244,479.25  
Revogenex, Inc. RVX-100 (L-HS) IND 105,364 Hysocyamine Sulfate $ 244,479.25  
Revogenex, Inc. RVX-109 (TRML) Tramadol Hydrochloride for Injection (IV) $ 204,277.25 $ 40,202.00
Salutria Pharmaceuticals LLC Development of Succinobucol to Reduce Cardiovascular Risk in Type 2 Diabetes Patients $ 244,479.24  
Sanuwave Inc dermaPace FDA IDE study for treating chrinic diabetic Foot ulcers $ 244,479.24  
Sebacia, Inc Sebacia Acne Therapy   $ 244,479.24
Serrg Savannah Inc CB-01-02/01 (Cosmo) $ 5,241.50  
Serrg Savannah Inc PTK 0796-CSSSI-0804 $ 26,206.50  
Serrg Savannah Inc NXL 103/2002 (Novexel) $ 20,965.00  
Serrg Savannah Inc GSK TOC110978 $ 7,748.50  
SoloHealth, Inc SoloHealth Health and Wellness Kiosk $ 244,479.25  
Southeast Regional Research Group  Inc CB-01-02/01(Cosmo) $ 2,305.00  
Southeast Regional Research Group  Inc PTK 0796-CSSSI-0804 $ 13,825.00  
Southeast Regional Research Group  Inc GSK TOC110978 $ 4,608.50  
Southeast Regional Research Group, Inc CE06-300(Cempra ABSSSI) $ 9,216.50  
Southeast Regional Research Group, Inc. CVRX $ 18,433.00  
Tissue Regeneration Technologies, LLC Software $ 126,172.00 $ 118,307.25
Transfusion & Transplantation Technologies INC. Aegis Automated Blood Analyzer $ 198,769.50 $ 45,709.75
Velocity Medical Solutions, LLc Imaging for Treatment Assessment and Response to Cancer Therapies $ 244,479.25  
Visioneering Technologies, Inc Development of a Novel Therapeutic to Treat and Prevent Myopia $ 244,479.25  
Zenda Technologies, Inc. DETECT - an immersive solution for neuropsychological testing in a primary care setting $ 167,354.00 $ 77,125.25
Zirus Inc The Development of Broadly Active and Orally Bioavailable Antiviral Drugs $ 244,479.24  

Rate the Small Business and Self-Employed Website

Page Last Reviewed or Updated: 21-Oct-2014